Advances and challenges in the mechanistic understanding of beta-cell dysfunction in gestational diabetes mellitus.
Level 5 - mechanism / opinion, no new human data
Narrative review of mechanisms and disease models without primary clinical data.
PubMed 42434800 · doi:10.1093/jas/skag212
What was done
The authors reviewed literature on the molecular and cellular mechanisms underlying pancreatic beta-cell dysfunction in gestational diabetes mellitus (GDM), examining the roles of glucotoxicity, proinflammatory cytokines, placental steroids, and lactogenic hormones, as well as the utility and limitations of current animal and cellular models.
What was found
The abstract provides a qualitative mechanistic overview and reports no quantitative outcome data or effect estimates. It notes that GDM affects approximately 14% of pregnancies and that research has predominantly focused on peripheral insulin resistance rather than islet beta-cell secretory failure.
Why it matters
Elucidating islet-level failure mechanisms in GDM is necessary to identify targeted therapies that prevent both adverse pregnancy outcomes and the long-term risk of type 2 diabetes in mothers and their children.
Limits
As a narrative review, it presents no new experimental or clinical data. Mechanistic investigation in this field remains constrained by the lack of fully physiological animal models and the scarcity of cadaveric human islet tissue for a transient, non-fatal condition.
Cited by
- supports Pregnancy induces a state of transient, adaptive insulin resistance.